Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 100.34 USD -2.37% Market Closed
Market Cap: 6.1B USD

Intrinsic Value

The intrinsic value of one JAZZ stock under the Base Case scenario is 311.32 USD. Compared to the current market price of 100.34 USD, Jazz Pharmaceuticals PLC is Undervalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JAZZ Intrinsic Value
311.32 USD
Undervaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jazz Pharmaceuticals PLC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
JAZZ
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for JAZZ cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
IE
Pharmaceuticals
Market Cap
6.1B USD
IPO
Jan 18, 2012
IE
Pharmaceuticals
Market Cap
6.1B USD
IPO
Jan 18, 2012
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about JAZZ?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Jazz Pharmaceuticals PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jazz Pharmaceuticals PLC

Current Assets 4.6B
Cash & Short-Term Investments 3B
Receivables 716.8m
Other Current Assets 919.4m
Non-Current Assets 7.4B
PP&E 227m
Intangibles 6.5B
Other Non-Current Assets 684.2m
Efficiency

Free Cash Flow Analysis
Jazz Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jazz Pharmaceuticals PLC

Revenue
4.1B USD
Cost of Revenue
-445.7m USD
Gross Profit
3.6B USD
Operating Expenses
-2.9B USD
Operating Income
726.6m USD
Other Expenses
-166.5m USD
Net Income
560.1m USD
Fundamental Scores

JAZZ Profitability Score
Profitability Due Diligence

Jazz Pharmaceuticals PLC's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
ROE is Increasing
Positive 3-Years Revenue Growth
58/100
Profitability
Score

Jazz Pharmaceuticals PLC's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

JAZZ Solvency Score
Solvency Due Diligence

Jazz Pharmaceuticals PLC's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average D/E
42/100
Solvency
Score

Jazz Pharmaceuticals PLC's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC

Wall Street analysts forecast JAZZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAZZ is 193.94 USD with a low forecast of 151.5 USD and a high forecast of 241.5 USD.

Lowest
Price Target
151.5 USD
51% Upside
Average
Price Target
193.94 USD
93% Upside
Highest
Price Target
241.5 USD
141% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Jazz Pharmaceuticals PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for JAZZ is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

JAZZ Insider Trading
Buy and sell transactions by insiders

JAZZ News

Other Videos
What is the Intrinsic Value of one JAZZ stock?

The intrinsic value of one JAZZ stock under the Base Case scenario is 311.32 USD.

Is JAZZ stock undervalued or overvalued?

Compared to the current market price of 100.34 USD, Jazz Pharmaceuticals PLC is Undervalued by 68%.

Back to Top